James Hermiller, MD
Interventional Cardiology · Indianapolis, INNPI 1619943263
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $188,051 of the $307,056 with a category attached, or 61.2%. 20 manufacturers reported payments, led by Abbott at 46.7% of the total. Reporting peaked in 2021 at $85,263 and has fallen 66.7% since, to $28,358 in 2025. Among interventional cardiology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 424 payments — averaging $724.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$143K
- Edwards Lifesciences$102K
- Medtronic$26K
- Biotronik Inc.$10K
- Livanova USA, Inc.$10K
- Boston Scientific$6K
- plus $10K from 14 others
Across 585 payments — averaging $4335.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Edwards Lifesciences$1.4M
- Abbott$908K
- Medtronic$124K
- Boston Scientific$89K
What the payments were for
- Consulting fees$188,05161%
- Speaking & faculty fees$68,61322%
- Grants$2,5001%
- Travel & lodging$29,58910%
- Food & beverage$18,2916%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 171 | $143,277 |
| Edwards Lifesciences | 119 | $102,456 |
| Medtronic(2 entities) | 64 | $25,876 |
| Biotronik Inc. | 13 | $10,117 |
| Livanova USA, Inc. | 5 | $9,606 |
| Boston Scientific | 22 | $5,901 |
| Artivion, Inc. | 2 | $3,600 |
| Teleflex LLC | 2 | $1,965 |
| ZOLL Circulation Inc | 1 | $1,125 |
| Shockwave Medical, Inc | 7 | $906 |
| W. L. Gore & Associates, Inc. | 1 | $800 |
| Philips North America LLC | 5 | $438 |
| Abiomed | 4 | $354 |
| Asahi Intecc USA, Inc. | 1 | $200 |
| Acist Medical Systems, Inc. | 1 | $167 |
| Biosense Webster, Inc. | 1 | $95 |
| Amgen | 1 | $76 |
| Siemens Medical Solutions USA, Inc. | 1 | $53 |
| AbbVie(2 entities) | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Edwards SAPIEN 3 Transcatheter Heart Valve$84,811
- AMPLATZER Occluders$37,387
- Mitra Clip system$28,654
- MitraClip$27,847
- Resolute$14,943
- AMPLATZER AMULET$13,113
- MitraClip System$11,700
- AMPLATZER$11,518
- TMVR$9,450
- Xience V coronary stent system$3,146
- ON-X AORTIC HEART VALVE WITH CONFORM-X SEWING RING AND EXTENDED HOLDER$3,000
- PORTICO$2,555
- GENERAL - STRUCTURAL HEART$2,500
- HeartMate$2,100
- Watchman$2,013
- Endurant$1,472
- TRICLIP$1,267
- RESOLUTE ONYX$1,243
- TherOx DS2 Console$1,125
- Catheter$1,125
How this compares
$307,056 in reported general payments places this provider in the 95th percentile of 170 interventional cardiology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 196 | $274,193 |
| EntrestoSacubitril/Valsartan | 56 | $82,516 |
| XareltoRivaroxaban | 57 | $72,418 |
| Repatha SureclickEvolocumab | 29 | $31,348 |
| Nebivolol Hcl | 75 | $5,198 |
| Metoprolol Succinate | 353 | $4,768 |
| Ezetimibe | 211 | $4,324 |
| Rosuvastatin Calcium | 375 | $3,603 |
| Valsartan | 103 | $3,334 |
| Carvedilol | 231 | $2,442 |
| Atorvastatin Calcium | 275 | $2,282 |
| ClopidogrelClopidogrel Bisulfate | 222 | $2,019 |
| Amlodipine Besylate | 196 | $1,482 |
| Torsemide | 71 | $1,339 |
| Losartan Potassium | 159 | $1,303 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Indianapolis
- Woodrow CoreyIndianapolis$262K
- Michael BallIndianapolis$76K
- Anjan SinhaIndianapolis$54K
- Nitesh GadeelaIndianapolis$48K
- George RevtyakIndianapolis$45K
- Scott SharpIndianapolis$41K
- Amrish MalhiIndianapolis$37K
- Jeffrey BreallIndianapolis$21K
- Sandeep DubeIndianapolis$21K
- Kevin BallIndianapolis$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.